AI and a urine test could revolutionize cervical cancer detection
NCT ID NCT06042543
Summary
This study is testing a new, all-in-one system designed to make cervical cancer screening simpler and more accessible in low-resource countries. It uses artificial intelligence (AI) to analyze a urine sample for signs of the virus that causes cervical cancer. For women who test positive, the AI then examines pictures of the cervix to look for precancerous changes and help decide on treatment. The goal is to validate this faster, more affordable approach with 3,200 women in Zimbabwe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Cincinnati
NOT_YET_RECRUITINGCincinnati, Ohio, 45221, United States
Contact Email: •••••@•••••
-
University of Zimbabwe
RECRUITINGHarare, 0002, Zimbabwe
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.